Stay updated on Elranatamab in Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Elranatamab in Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the Elranatamab in Refractory Multiple Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision: v3.3.3 has been added, and HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedVersion 51 was submitted on 2025-12-02, adding updates to the Contacts/Locations and Study Status sections of the record history. A prior version (50) appears to have been deleted on 2025-10-20.SummaryDifference0.3%

- Check47 days agoChange DetectedThe page history now shows a new revision entry (v3.3.2) replacing the earlier v3.2.0; no substantive study data or status changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedRemoved the government funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check69 days agoChange DetectedRecord History page shows minor layout/formatting changes to the Version history list with no alteration to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check97 days agoChange DetectedThe page now displays an updated government operating status notice and revision to v3.2.0, with a current date; an older date and v3.1.0 have been removed.SummaryDifference10%

Stay in the know with updates to Elranatamab in Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab in Refractory Multiple Myeloma Clinical Trial page.